Our results showed that HO-1 inhibition significantly increased CD4+ T cell infiltration in the tumor tissues of the combined treatment group in WT-RM-1-parent mice, compared to each treatment alone and the control group (P < 0.05) (Fig. 4E and F). The gene discussed is HMOX1; the disease is neoplasm.